Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

First post-IPO results from Circassia

Country: United Kingdom

Circassia Pharmaceuticals Plc reported an operating loss of £19.5 million for the first six months of the year as spending nearly doubled on the development of four clinical-stage immunotherapies for allergy, the most of advanced of which is in Phase 3.

Read more

Cancer medicines get regulatory nod

Country: United Kingdom

In separate decisions, regulatory authorities in the US and Europe have paved the way for the introduction of two new medicines for different blood cancers – substantially increasing the treatment options for patients with a number of rare cancers.

Read more

Breast cancer drugs drive sales at Roche

Country: Switzerland

Read more

GSK sales and profit fall in Q2

Country: United Kingdom

Read more

Update on the human embryo

Country: Luxembourg

Read more

Sobi increases revenue by 27%

Country: Sweden

Read more

AbbVie wins Shire for £32 billion

Country: United States

Read more

Novartis had modest Q2 sales gain

Country: Switzerland

Read more

GSK melanoma trial stopped early

Country: United Kingdom

Read more

Protein structure displayed

Country: United Kingdom

Read more

Dengue vaccine effective

Country: France

Read more

FDA approves Ruconest for HAE

Country: Netherlands

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Gently pushing the accelerator in cancer by Frederic Triebel

FredericTriebel.pdf

Highlights of the July-Aug 2014 MedNous issue

The July-Aug 2014 MedNous features:

Latest Mednous cover
  • Business Strategy
    Why Big Pharma is
    seizing the orphan drug
    opportunity
  • Oncology
    Hitting the accelerator
    in immunotherapy
    By Frederic Triebel
  • Regulatory
    Next step for clinical trial
    transparency
  • Commentary
    Who has the lead in
    genomic research?
    By Florian Bazant-Hegemark
    and Gareth Williams
  • Markets
    Quarterly stock market review
    AbbVie wins Shire

The latest MedNous journal. Subscribe to download.